Authors:
Dahlof, C
Tfelt-Hansen, P
Massiou, H
Fazekas, A
Citation: C. Dahlof et al., Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine, NEUROLOGY, 57(10), 2001, pp. 1811-1817
Authors:
Lipton, RB
Pascual, J
Goadsby, PJ
Massiou, H
McCarroll, KA
Vandormael, K
Jiang, KH
Lines, CR
Citation: Rb. Lipton et al., Effect of rizatriptan and other triptans on the nausea symptom of migraine: A post hoc analysis, HEADACHE, 41(8), 2001, pp. 754-763
Citation: H. Massiou et C. Valette, Quality of life in migraine patients given 2.5 mg oral naratriptan for 12 weeks, PRESSE MED, 29(38), 2000, pp. 2087-2091
Authors:
Tfelt-Hansen, P
Block, G
Dahlof, C
Diener, HC
Ferrari, MD
Goadsby, PJ
Guidetti, V
Jones, B
Lipton, RB
Massiou, H
Meinert, C
Sandrini, G
Steiner, T
Winter, PBO
Citation: P. Tfelt-hansen et al., Guidelines for controlled trials of drugs in migraine: second edition, CEPHALALGIA, 20(9), 2000, pp. 765-786
Authors:
Bousser, MG
Conard, J
Kittner, S
de Lignieres, B
MacGregor, EA
Massiou, H
Silberstein, SD
Tzourio, C
Citation: Mg. Bousser et al., Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine, CEPHALALGIA, 20(3), 2000, pp. 155-156